Ophthalmic Drugs Market | Global Industry Analysis 2017-2024 | Inkwood Research

1
Ophthalmic Drugs Market
To Request A Free Sample Copy Of This Report,
Please Click Below Link
https//www.inkwoodresearch.com/reports/ophthalmic
-drugs-market-forecast-2017-2024

• Global Market Trends, Analysis Outlook
  2017-2024

www.inkwoodresearch.com
2
Report Summary

• The global ophthalmic drugs market is estimated
  to grow at an approximate CAGR of 7.86 during
  the period of 2017 and 2024.
• An existing predominance and increase in the
  number of eye disorders with growing geriatric
  population all over the world are the primary
  drivers responsible for the market growth.
• With increasing awareness of ophthalmic drugs
  among the consumers and patients is anticipated
  to proliferate the market growth.

3
Market Insights

• The ophthalmic drugs market is segmented on the
  basis of End-user, Prescription type, and
  Geography.
• The Prescription type ophthalmic drugs market is
  segregated into Prescription Market for
  Ophthalmic Drugs and OTC (Over the Counter Drugs)
  Market for Ophthalmic Drugs.
• The End-user ophthalmic drugs market is
  segregated into Hospitals, Eye Clinics,
  Diagnostic Centers, and Patients. The ophthalmic
  drugs market on the basis of Geography is
  segregated into Asia-Pacific, Europe, North
  America, Middle East Africa and Central South
  America.
• The technological advancements, rise in eye
  disorders, growth in geriatric population,
  cataract surgeries and upsurge in healthcare
  expenditure are dominant drivers for the growth
  of ophthalmic drugs market.

4
Market Insights

• A vast scope for ophthalmic drugs market is
  created with the predominance of eye-related
  disorders and ailments.
• One major cause for half-blindness and decreased
  vision is Cataract with the highest percentage
  accountable of worldwide visual impairment.
• Cataract surgery is risk-free and secure kind of
  surgery the safety has led to an increase in the
  cataract surgeries.
• The boost in Health expenditure has boosted the
  consumer spending indirectly driving the
  ophthalmic drugs market.

5
Market Share
6
Competitive Insights

• The predominant ophthalmic drugs companies in the
  global market are Bayer, Akorn, Johnson and
  Johnson, Abbott Laboratories, Valeant, Allergan
  Inc., Regeneron, Merck Co., Pfizer Inc., Lpath
  Incorporated, Novartis Ag, Roche Holding Ag,
  Eyegate Pharmaceuticals, GlaxoSmithKline, Santen
  Pharmaceutical Co. Ltd, Sun Pharmaceuticals
  Industries, Ltd., Senju Pharmaceutical Co., Ltd,
  Cipla Pharmaceuticals and EyeMed.

7
Report Segmentation
EUROPE GERMANY UNITED KINGDOM(UK) RUSSIA FRANCE I
TALY SPAIN ASIA PACIFIC CHINA INDIA SOUTH
KOREA JAPAN AUSTRALIA MIDDLE EAST
AFRICA CENTRAL SOUTH AMERICA
GLOBAL OPHTHALMIC DRUGS MARKET BY PRESCRIPTION
TYPE GLOBAL PRESCRIPTION MARKET FOR OPHTHALMIC
DRUGS GLOBAL OTC (OVER THE COUNTER DRUGS) MARKET
FOR OPHTHALMIC DRUGS GLOBAL OPHTHALMIC DRUGS
MARKET BY END USER GLOBAL HOSPITALS OPHTHALMIC
DRUGS MARKET GLOBAL EYE CLINICS OPHTHALMIC DRUGS
MARKET GLOBAL DIAGNOSTIC CENTERS OPHTHALMIC DRUGS
MARKET GLOBAL PATIENTS OPHTHALMIC DRUGS
MARKET REGIONAL ANALYSISNORTH AMERICA UNITED
STATES (U.S.) CANADA MEXICO
8
Request a Free Sample
To Request A Free Sample Copy Of This Report,
Please Click The Link Below
https//www.inkwoodresearch.com/reports/ophthalmic
-drugs-market-forecast-2017-2024
9
About Us
Inkwood Research specializes in syndicated
research reports, customized research reports and
consulting services. We offer market intelligence
studies across a range of industries including
Technology, Chemicals, Materials, Healthcare and
Energy. With 20 years of research experience, we
ensure you efficient deliverables with global and
country industry knowledge and research
expertise. Our analysis covers North South
America, Europe, CEE, CIS, Middle East, Africa
and Asia.
10
Contact Us
169, Harrison Avenue Boston, MA 02111. 1
857-302-4704 Sales_at_inkwoodresearch.com www.inkwood
research.com